Luxfer (LXFR) Financials

$11.58 -0.38 (-3.14%)

Closing price 05/21/2025 03:59 PM Eastern

Extended Trading

$11.62 +0.04 (+0.35%)

As of 05/21/2025 04:04 PM Eastern

Annual Income Statements for Luxfer

This table shows Luxfer's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	18	-1.90	27
Consolidated Net Income / (Loss)	18	-1.90	27
Net Income / (Loss) Continuing Operations	18	-2.60	32
Total Pre-Tax Income	27	-9.70	41
Total Operating Income	30	4.20	45
Total Gross Profit	86	77	95
Total Revenue	392	405	423
Operating Revenue	392	405	423
Total Cost of Revenue	306	328	328
Operating Cost of Revenue	306	328	328
Total Operating Expenses	56	72	50
Selling, General & Admin Expense	48	49	43
Research & Development Expense	4.40	4.60	4.90
Other Operating Expenses / (Income)	-1.60	0.00	0.30
Impairment Charge	0.00	13	0.00
Restructuring Charge	4.70	6.40	1.90
Total Other Income / (Expense), net	-3.60	-14	-3.80
Interest Expense	5.20	6.30	3.90
Other Income / (Expense), net	1.60	-7.60	0.10
Income Tax Expense	8.20	-7.10	9.00
Net Income / (Loss) Discontinued Operations	0.10	0.70	-5.10
Basic Earnings per Share	$0.69	($0.07)	$0.99
Weighted Average Basic Shares Outstanding	26.74M	26.83M	26.93M
Diluted Earnings per Share	$0.68	($0.07)	$0.98
Weighted Average Diluted Shares Outstanding	26.74M	26.83M	26.93M
Weighted Average Basic & Diluted Shares Outstanding	26.74M	26.83M	26.93M

This table shows Luxfer's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	9/25/2022
Net Income / (Loss) Attributable to Common Shareholders	5.50	3.50	13	-0.50	2.70	-5.80	-1.30	4.70	0.50	2.00	8.00
Consolidated Net Income / (Loss)	5.50	3.50	13	-0.50	2.70	-5.80	-1.30	4.70	0.50	2.00	8.00
Net Income / (Loss) Continuing Operations	5.50	3.30	13	-0.40	2.80	-6.50	-1.50	4.90	0.50	6.20	8.50
Total Pre-Tax Income	7.40	3.70	16	2.70	3.80	-13	-0.80	6.70	-3.10	8.00	11
Total Operating Income	7.60	4.00	17	3.80	4.90	-11	0.50	7.90	7.10	10	12
Total Gross Profit	21	23	22	22	18	17	15	24	21	22	23
Total Revenue	97	103	99	100	89	96	97	110	101	117	100
Operating Revenue	97	103	99	100	89	96	97	110	101	117	100
Other Revenue	0.00	-	-	-	-	-	0.00	0.00	0.00	-	-
Total Cost of Revenue	76	81	77	78	71	79	83	86	80	95	77
Operating Cost of Revenue	76	81	77	78	71	79	83	86	80	95	77
Total Operating Expenses	14	19	5.00	18	14	28	14	16	14	12	12
Selling, General & Admin Expense	13	13	11	12	12	12	11	13	13	11	10
Research & Development Expense	1.10	1.10	1.00	1.10	1.20	1.20	1.20	1.00	1.20	1.40	1.00
Other Operating Expenses / (Income)	0.00	-3.90	-1.80	4.10	0.00	-	0.00	0.00	0.00	-	0.00
Restructuring Charge	0.10	2.40	0.50	1.10	0.70	2.00	1.60	2.50	0.30	-0.10	0.30
Total Other Income / (Expense), net	-0.20	-0.30	-1.10	-1.10	-1.10	-1.20	-1.30	-1.20	-10	-2.00	-0.80
Interest Expense	0.80	1.10	1.40	1.30	1.40	1.60	1.60	1.80	1.30	1.20	1.00
Other Income / (Expense), net	0.60	0.80	0.30	0.20	0.30	0.40	0.30	0.60	-8.90	-0.80	0.20
Income Tax Expense	1.90	0.40	3.70	3.10	1.00	-6.00	0.70	1.80	-3.60	1.80	2.30
Net Income / (Loss) Discontinued Operations	0.00	0.20	0.10	-0.10	-0.10	0.70	0.20	-0.20	0.00	-4.20	-0.50
Basic Earnings per Share	$0.21	$0.14	$0.47	($0.02)	$0.10	($0.21)	($0.05)	$0.17	$0.02	$0.08	$0.29
Weighted Average Basic Shares Outstanding	26.73M	26.74M	26.81M	26.83M	26.82M	26.83M	26.90M	26.92M	26.92M	26.93M	27.30M
Diluted Earnings per Share	$0.20	$0.13	$0.47	($0.02)	$0.10	($0.21)	($0.05)	$0.17	$0.02	$0.07	$0.29
Weighted Average Diluted Shares Outstanding	27.13M	26.74M	26.93M	26.93M	26.87M	26.83M	27.02M	27.07M	27.07M	26.93M	27.53M
Weighted Average Basic & Diluted Shares Outstanding	26.77M	26.74M	26.78M	27.39M	26.84M	26.83M	26.87M	26.92M	26.93M	26.93M	27.21M

This table details how cash moves in and out of Luxfer's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	3.70	-10	6.50
Net Cash From Operating Activities	51	26	16
Net Cash From Continuing Operating Activities	51	26	16
Net Income / (Loss) Continuing Operations	18	-2.60	32
Consolidated Net Income / (Loss)	18	-1.90	27
Net Income / (Loss) Discontinued Operations	0.10	0.70	-5.10
Depreciation Expense	13	12	17
Amortization Expense	1.10	4.50	1.20
Non-Cash Adjustments To Reconcile Net Income	9.10	24	3.20
Changes in Operating Assets and Liabilities, net	10	-12	-38
Net Cash From Discontinued Operating Activities	0.00	0.10	0.10
Net Cash From Investing Activities	-3.40	-9.50	-5.70
Net Cash From Continuing Investing Activities	-3.40	-9.40	-5.60
Purchase of Property, Plant & Equipment	-10	-9.40	-8.30
Acquisitions	-0.40	0.00	0.00
Sale of Property, Plant & Equipment	0.00	0.00	3.70
Other Investing Activities, net	7.30	0.00	-1.00
Net Cash From Discontinued Investing Activities	0.00	-0.10	-0.10
Net Cash From Financing Activities	-44	-28	-2.00
Net Cash From Continuing Financing Activities	-44	-28	-2.00
Repayment of Debt	-27	-10	25
Repurchase of Common Equity	-2.30	-2.70	-11
Payment of Dividends	-14	-14	-14
Other Financing Activities, net	-0.50	-0.40	-1.40
Effect of Exchange Rate Changes	0.00	0.40	-1.70
Cash Interest Paid	5.80	6.10	4.00
Cash Income Taxes Paid	-1.20	3.30	0.60

This table details how cash moves in and out of Luxfer's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	9/25/2022
Net Change in Cash & Equivalents	0.00	2.20	-0.50	-2.50	4.50	2.20	-7.80	6.10	-11	1.40	6.00
Net Cash From Operating Activities	5.40	26	13	8.90	3.70	16	12	13	-14	19	3.60
Net Cash From Continuing Operating Activities	5.20	26	13	8.90	3.60	16	12	13	-14	19	3.60
Net Income / (Loss) Continuing Operations	5.50	3.30	13	-0.40	2.80	-6.50	-1.50	4.90	0.50	6.20	8.50
Consolidated Net Income / (Loss)	5.50	3.50	13	-0.50	2.70	-5.80	-1.30	4.70	0.50	2.00	8.00
Net Income / (Loss) Discontinued Operations	0.00	0.20	0.10	-0.10	-0.10	0.70	0.20	-0.20	0.00	-4.20	-0.50
Depreciation Expense	2.90	5.70	2.40	2.30	2.20	2.70	3.00	3.10	3.10	7.50	3.10
Amortization Expense	0.30	0.30	0.30	0.20	0.30	3.60	0.30	0.30	0.30	0.20	0.30
Non-Cash Adjustments To Reconcile Net Income	0.30	6.30	-5.60	7.50	0.90	14	3.10	0.30	7.20	2.50	0.70
Changes in Operating Assets and Liabilities, net	-3.80	10	3.20	-0.70	-2.60	2.50	8.60	2.50	-26	2.60	-9.00
Net Cash From Discontinued Operating Activities	0.20	-0.20	0.10	-	0.10	-	-	0.10	0.00	0.10	-
Net Cash From Investing Activities	-1.40	4.50	-3.70	-2.70	-1.50	-1.90	-2.60	-3.00	-2.00	-4.20	-2.30
Net Cash From Continuing Investing Activities	-1.20	4.30	-3.60	-2.70	-1.40	-1.90	-2.60	-2.90	-2.00	-4.10	-2.30
Purchase of Property, Plant & Equipment	-1.20	-3.00	-3.20	-2.70	-1.40	-1.90	-2.60	-2.90	-2.00	-3.10	-2.30
Net Cash From Discontinued Investing Activities	-0.20	0.20	-0.10	-	-0.10	-	-	-0.10	0.00	-0.10	-
Net Cash From Financing Activities	-4.20	-28	-10	-8.60	2.30	-12	-17	-4.10	5.30	-15	6.70
Net Cash From Continuing Financing Activities	-4.20	-28	-10	-8.60	2.30	-12	-17	-4.10	5.30	-15	6.70
Repayment of Debt	-2.00	-23	-5.80	6.30	-4.30	-7.90	-38	35	0.00	-6.90	14
Repurchase of Common Equity	-0.50	-0.70	-0.60	-0.60	-0.40	-0.50	-0.60	-0.80	-0.80	-4.20	-3.30
Payment of Dividends	-3.50	-3.50	-3.50	-3.50	-3.50	-3.50	-3.50	-3.50	-3.50	-3.60	-3.60
Issuance of Debt	2.20	-	-	-	11	-	-	-35	9.90	-	-
Other Financing Activities, net	-0.40	-0.10	-0.10	-0.20	-0.10	-0.10	-	-	-0.30	-	-
Effect of Exchange Rate Changes	0.20	-0.10	0.20	-0.10	0.00	0.10	-	-	0.30	1.20	-2.00
Cash Interest Paid	0.80	1.40	1.60	1.40	1.40	1.30	2.00	1.40	1.40	1.20	1.10
Cash Income Taxes Paid	0.20	-1.70	0.20	-	-	0.50	-	-	-	-1.60	1.90

This table presents Luxfer's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	382	372	407
Total Current Assets	176	169	201
Cash & Equivalents	4.10	2.30	13
Restricted Cash	2.20	0.30	0.30
Accounts Receivable	59	54	68
Inventories, net	84	96	111
Prepaid Expenses	4.60	5.70	-
Other Current Assets	0.00	1.50	0.00
Other Current Nonoperating Assets	23	8.90	9.30
Plant, Property, & Equipment, net	63	64	78
Total Noncurrent Assets	144	140	128
Long-Term Investments	0.40	0.40	0.40
Goodwill	67	68	66
Intangible Assets	12	12	13
Noncurrent Deferred & Refundable Income Taxes	4.10	3.90	3.00
Employee Benefit Assets	49	40	27
Other Noncurrent Operating Assets	12	15	20
Total Liabilities & Shareholders' Equity	382	372	407
Total Liabilities	163	160	200
Total Current Liabilities	94	65	110
Short-Term Debt	3.10	4.60	25
Accounts Payable	30	27	38
Accrued Expenses	24	21	29
Current Deferred & Payable Income Tax Liabilities	5.60	0.00	1.80
Other Current Liabilities	19	8.90	11
Other Current Nonoperating Liabilities	13	3.90	5.00
Total Noncurrent Liabilities	69	95	90
Long-Term Debt	42	68	56
Noncurrent Deferred & Payable Income Tax Liabilities	14	10	9.90
Noncurrent Employee Benefit Liabilities	0.10	0.10	4.50
Other Noncurrent Operating Liabilities	13	17	19
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	220	213	207
Total Preferred & Common Equity	220	213	207
Total Common Equity	220	213	207
Common Stock	253	250	248
Retained Earnings	109	104	120
Treasury Stock	-25	-23	-20
Accumulated Other Comprehensive Income / (Loss)	-116	-118	-139
Other Equity Adjustments	-0.80	-0.90	-1.00

This table presents Luxfer's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/30/2025	9/29/2024	6/30/2024	3/31/2024	10/1/2023	7/2/2023	4/2/2023	9/25/2022
Total Assets	385	405	380	386	393	415	421	392
Total Current Assets	176	196	179	185	190	207	214	198
Cash & Equivalents	4.10	3.50	4.30	6.80	1.20	7.90	1.80	11
Restricted Cash	2.20	0.60	0.30	0.30	0.30	0.30	0.30	0.30
Accounts Receivable	54	75	61	60	70	72	74	66
Inventories, net	86	94	88	89	110	119	129	112
Prepaid Expenses	4.50	-	-	-	-	-	-	-
Other Current Nonoperating Assets	24	22	23	28	9.10	7.80	7.80	9.10
Plant, Property, & Equipment, net	63	66	63	63	75	77	78	75
Total Noncurrent Assets	147	143	138	138	128	131	130	119
Long-Term Investments	0.40	0.40	0.40	0.40	0.30	0.30	0.30	0.30
Goodwill	68	70	67	67	66	68	67	63
Intangible Assets	11	12	12	12	12	12	12	12
Noncurrent Deferred & Refundable Income Taxes	3.70	3.10	3.50	3.70	2.90	3.00	3.20	7.10
Employee Benefit Assets	52	44	41	41	29	30	28	14
Other Noncurrent Operating Assets	11	14	14	15	18	18	19	23
Total Liabilities & Shareholders' Equity	385	405	380	386	393	415	421	392
Total Liabilities	159	180	174	176	188	200	179	197
Total Current Liabilities	87	90	75	72	80	78	112	111
Short-Term Debt	1.10	3.70	0.20	0.30	1.10	0.00	-	25
Accounts Payable	29	28	28	31	39	36	39	28
Accrued Expenses	24	33	23	23	21	24	29	33
Current Deferred & Payable Income Tax Liabilities	8.40	8.50	5.10	2.30	1.30	1.10	-	7.80
Other Current Liabilities	9.30	9.90	9.40	8.00	13	13	12	13
Other Current Nonoperating Liabilities	15	7.20	9.40	8.00	4.20	3.50	4.10	4.90
Total Noncurrent Liabilities	72	89	99	103	107	122	95	86
Long-Term Debt	45	66	74	78	79	92	66	62
Noncurrent Deferred & Payable Income Tax Liabilities	14	10	10	10	11	11	11	2.70
Noncurrent Employee Benefit Liabilities	0.10	0.00	0.00	0.00	0.00	0.00	0.00	2.30
Other Noncurrent Operating Liabilities	13	13	15	15	17	18	18	20
Commitments & Contingencies	0.00	0.00	0.00	-	0.00	0.00	-	-
Total Equity & Noncontrolling Interests	227	225	206	210	205	215	214	195
Total Preferred & Common Equity	227	225	206	210	205	215	214	195
Total Common Equity	227	225	206	210	205	215	214	195
Common Stock	253	251	251	250	249	249	248	247
Retained Earnings	111	109	100	104	110	115	117	122
Treasury Stock	-25	-24	-24	-23	-22	-22	-21	-16
Accumulated Other Comprehensive Income / (Loss)	-111	-110	-120	-119	-131	-126	-129	-157
Other Equity Adjustments	-0.80	-0.80	-0.80	-0.90	-0.90	-0.90	-1.00	-0.90

This table displays calculated financial ratios and metrics derived from Luxfer's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-3.23%	-4.35%	13.12%
EBITDA Growth	249.23%	-79.50%	16.12%
EBIT Growth	1,032.35%	-107.57%	16.62%
NOPAT Growth	607.01%	-91.59%	13.98%
Net Income Growth	1,068.42%	-107.06%	-10.03%
EPS Growth	1,071.43%	-107.14%	-8.41%
Operating Cash Flow Growth	94.30%	65.41%	-39.08%
Free Cash Flow Firm Growth	1,768.45%	-115.69%	162.42%
Invested Capital Growth	-10.33%	2.18%	6.32%
Revenue Q/Q Growth	1.95%	-4.88%	4.39%
EBITDA Q/Q Growth	70.04%	-56.81%	11.03%
EBIT Q/Q Growth	98.13%	-120.36%	7.67%
NOPAT Q/Q Growth	70.19%	-87.67%	13.41%
Net Income Q/Q Growth	102.20%	-132.20%	9.80%
EPS Q/Q Growth	100.00%	-133.33%	8.89%
Operating Cash Flow Q/Q Growth	22.84%	-10.54%	241.96%
Free Cash Flow Firm Q/Q Growth	216.30%	-126.09%	180.73%
Invested Capital Q/Q Growth	-9.81%	-0.65%	1.80%
Profitability Metrics	-	-	-
Gross Margin	21.87%	18.91%	22.44%
EBITDA Margin	11.58%	3.21%	14.97%
Operating Margin	7.68%	1.04%	10.58%
EBIT Margin	8.09%	-0.84%	10.60%
Profit (Net Income) Margin	4.70%	-0.47%	6.35%
Tax Burden Percent	69.43%	19.59%	65.61%
Interest Burden Percent	83.60%	285.29%	91.31%
Effective Tax Rate	30.94%	0.00%	21.95%
Return on Invested Capital (ROIC)	7.92%	1.07%	13.30%
ROIC Less NNEP Spread (ROIC-NNEP)	2.78%	-6.50%	-1.46%
Return on Net Nonoperating Assets (RNNOA)	0.60%	-1.98%	-0.38%
Return on Equity (ROE)	8.52%	-0.91%	12.92%
Cash Return on Invested Capital (CROIC)	18.81%	-1.08%	7.18%
Operating Return on Assets (OROA)	8.40%	-0.87%	11.57%
Return on Assets (ROA)	4.88%	-0.49%	6.93%
Return on Common Equity (ROCE)	8.52%	-0.91%	12.92%
Return on Equity Simple (ROE_SIMPLE)	8.38%	-0.89%	12.98%
Net Operating Profit after Tax (NOPAT)	21	2.94	35
NOPAT Margin	5.30%	0.73%	8.26%
Net Nonoperating Expense Percent (NNEP)	5.14%	7.57%	14.76%
Return On Investment Capital (ROIC_SIMPLE)	7.86%	1.03%	12.12%
Cost of Revenue to Revenue	78.13%	81.09%	77.56%
SG&A Expenses to Revenue	12.27%	12.02%	10.18%
R&D to Revenue	1.12%	1.14%	1.16%
Operating Expenses to Revenue	14.19%	17.88%	11.86%
Earnings before Interest and Taxes (EBIT)	32	-3.40	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	45	13	63
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.57	1.05	1.62
Price to Tangible Book Value (P/TBV)	2.44	1.68	2.60
Price to Revenue (P/Rev)	0.88	0.55	0.79
Price to Earnings (P/E)	18.70	0.00	12.47
Dividend Yield	4.05%	6.23%	4.18%
Earnings Yield	5.35%	0.00%	8.02%
Enterprise Value to Invested Capital (EV/IC)	1.54	1.06	1.49
Enterprise Value to Revenue (EV/Rev)	0.98	0.72	0.95
Enterprise Value to EBITDA (EV/EBITDA)	8.42	22.57	6.36
Enterprise Value to EBIT (EV/EBIT)	12.06	0.00	8.98
Enterprise Value to NOPAT (EV/NOPAT)	18.40	99.80	11.54
Enterprise Value to Operating Cash Flow (EV/OCF)	7.48	11.16	25.37
Enterprise Value to Free Cash Flow (EV/FCFF)	7.74	0.00	21.38
Leverage & Solvency	-	-	-
Debt to Equity	0.21	0.34	0.39
Long-Term Debt to Equity	0.19	0.32	0.27
Financial Leverage	0.22	0.30	0.26
Leverage Ratio	1.75	1.86	1.86
Compound Leverage Factor	1.46	5.29	1.70
Debt to Total Capital	17.04%	25.35%	28.15%
Short-Term Debt to Total Capital	1.17%	1.62%	8.67%
Long-Term Debt to Total Capital	15.87%	23.74%	19.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	82.96%	74.65%	71.85%
Debt to EBITDA	0.99	5.55	1.28
Net Debt to EBITDA	0.85	5.32	1.07
Long-Term Debt to EBITDA	0.93	5.20	0.89
Debt to NOPAT	2.17	24.56	2.32
Net Debt to NOPAT	1.85	23.54	1.94
Long-Term Debt to NOPAT	2.02	22.99	1.61
Altman Z-Score	3.22	2.63	3.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.88	2.60	1.82
Quick Ratio	0.67	0.87	0.73
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	49	-2.96	19
Operating Cash Flow to CapEx	496.12%	279.79%	345.65%
Free Cash Flow to Firm to Interest Expense	9.50	-0.47	4.84
Operating Cash Flow to Interest Expense	9.83	4.17	4.08
Operating Cash Flow Less CapEx to Interest Expense	7.85	2.68	2.90
Efficiency Ratios	-	-	-
Asset Turnover	1.04	1.04	1.09
Accounts Receivable Turnover	6.94	6.64	6.74
Inventory Turnover	3.41	3.17	3.26
Fixed Asset Turnover	6.19	5.72	5.13
Accounts Payable Turnover	10.92	10.21	9.45
Days Sales Outstanding (DSO)	52.62	54.98	54.14
Days Inventory Outstanding (DIO)	106.98	115.04	112.03
Days Payable Outstanding (DPO)	33.44	35.73	38.62
Cash Conversion Cycle (CCC)	126.17	134.28	127.55
Capital & Investment Metrics	-	-	-
Invested Capital	248	277	271
Invested Capital Turnover	1.49	1.48	1.61
Increase / (Decrease) in Invested Capital	-29	5.90	16
Enterprise Value (EV)	382	293	403
Market Capitalization	344	224	335
Book Value per Share	$8.19	$7.91	$7.62
Tangible Book Value per Share	$5.26	$4.95	$4.75
Total Capital	265	285	289
Total Debt	45	72	81
Total Long-Term Debt	42	68	56
Net Debt	38	69	68
Capital Expenditures (CapEx)	10	9.40	4.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	79	106	103
Debt-free Net Working Capital (DFNWC)	85	109	116
Net Working Capital (NWC)	82	104	91
Net Nonoperating Expense (NNE)	2.39	4.84	8.07
Net Nonoperating Obligations (NNO)	29	64	64
Total Depreciation and Amortization (D&A)	14	16	19
Debt-free, Cash-free Net Working Capital to Revenue	20.13%	26.17%	24.33%
Debt-free Net Working Capital to Revenue	21.74%	26.81%	27.37%
Net Working Capital to Revenue	20.95%	25.68%	21.47%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.69	($0.07)	$0.99
Adjusted Weighted Average Basic Shares Outstanding	26.74M	26.90M	27.30M
Adjusted Diluted Earnings per Share	$0.68	($0.07)	$0.98
Adjusted Weighted Average Diluted Shares Outstanding	26.74M	27.02M	27.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.74M	26.83M	26.93M
Normalized Net Operating Profit after Tax (NOPAT)	24	16	36
Normalized NOPAT Margin	6.13%	4.03%	8.61%
Pre Tax Income Margin	6.76%	-2.40%	9.68%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	6.10	-0.54	11.51
NOPAT to Interest Expense	4.00	0.47	8.97
EBIT Less CapEx to Interest Expense	4.12	-2.03	10.33
NOPAT Less CapEx to Interest Expense	2.02	-1.03	7.79
Payout Ratios	-	-	-
Dividend Payout Ratio	76.09%	-736.84%	52.79%
Augmented Payout Ratio	88.59%	-878.95%	94.42%

This table displays calculated financial ratios and metrics derived from Luxfer's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	9/25/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.50%	7.82%	2.05%	-9.69%	-11.75%	-17.82%	-2.79%	0.82%	4.43%	18.00%	9.87%
EBITDA Growth	34.12%	334.78%	397.56%	-45.38%	381.25%	-127.22%	-73.03%	-27.44%	-89.26%	59.43%	21.60%
EBIT Growth	57.69%	144.04%	2,112.50%	-52.94%	388.89%	-218.48%	-93.22%	-34.11%	-116.36%	53.33%	35.63%
NOPAT Growth	56.45%	145.10%	3,742.94%	-109.74%	-27.35%	-202.06%	-96.17%	-42.68%	-37.89%	113.38%	48.40%
Net Income Growth	103.70%	160.34%	1,076.92%	-110.64%	440.00%	-390.00%	-116.25%	-49.46%	-93.42%	600.00%	66.67%
EPS Growth	100.00%	161.90%	1,040.00%	-111.76%	400.00%	-400.00%	-117.24%	-50.00%	-92.86%	800.00%	70.59%
Operating Cash Flow Growth	45.95%	59.38%	13.04%	-32.58%	125.69%	-16.23%	219.44%	428.00%	-54.84%	338.75%	-62.89%
Free Cash Flow Firm Growth	-77.04%	332.93%	238.69%	283.68%	245.77%	-65.39%	73.04%	62.65%	42.23%	85.42%	-248.49%
Invested Capital Growth	-1.72%	-10.33%	-1.22%	-11.30%	-13.44%	2.18%	4.70%	8.70%	13.24%	6.32%	25.58%
Revenue Q/Q Growth	-6.19%	4.02%	-0.30%	11.52%	-6.78%	-1.54%	-11.78%	8.98%	-13.20%	16.47%	-8.49%
EBITDA Q/Q Growth	5.56%	-47.06%	213.85%	-15.58%	197.47%	-212.20%	-65.55%	643.75%	-87.20%	11.18%	-7.32%
EBIT Q/Q Growth	70.83%	-72.88%	342.50%	-23.08%	147.71%	-1,462.50%	-90.59%	572.22%	-119.57%	-22.03%	-8.53%
NOPAT Q/Q Growth	58.33%	-73.48%	2,489.20%	-115.59%	145.65%	-2,360.00%	-93.94%	16.25%	-35.87%	-15.11%	-9.43%
Net Income Q/Q Growth	57.14%	-72.44%	2,640.00%	-118.52%	146.55%	-346.15%	-127.66%	840.00%	-75.00%	-75.00%	-13.98%
EPS Q/Q Growth	53.85%	-72.34%	2,450.00%	-120.00%	147.62%	-320.00%	-129.41%	750.00%	-71.43%	-75.86%	-14.71%
Operating Cash Flow Q/Q Growth	-78.82%	96.15%	46.07%	140.54%	-76.88%	39.13%	-12.88%	191.67%	-175.39%	430.56%	44.00%
Free Cash Flow Firm Q/Q Growth	-68.45%	90.90%	-48.53%	-25.95%	420.13%	-13.66%	31.83%	41.24%	-263.23%	81.47%	5.55%
Invested Capital Q/Q Growth	3.51%	-9.81%	5.24%	0.04%	-5.56%	-0.65%	-5.50%	-2.38%	11.48%	1.80%	-1.88%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.06%	22.15%	22.54%	22.07%	20.58%	17.41%	14.99%	21.92%	20.83%	18.77%	23.15%
EBITDA Margin	11.75%	10.44%	20.52%	6.52%	8.61%	-4.80%	4.21%	10.78%	1.58%	14.48%	15.17%
Operating Margin	7.84%	3.87%	17.51%	3.81%	5.48%	-11.78%	0.51%	7.16%	7.01%	8.57%	11.58%
EBIT Margin	8.45%	4.64%	17.81%	4.01%	5.82%	-11.37%	0.82%	7.70%	-1.78%	7.88%	11.78%
Profit (Net Income) Margin	5.67%	3.38%	12.78%	-0.50%	3.02%	-6.05%	-1.33%	4.26%	0.49%	1.71%	7.98%
Tax Burden Percent	74.32%	94.59%	77.91%	-18.52%	71.05%	46.40%	162.50%	70.15%	-16.13%	25.00%	74.07%
Interest Burden Percent	90.24%	77.08%	92.09%	67.50%	73.08%	114.68%	-100.00%	78.82%	172.22%	86.96%	91.53%
Effective Tax Rate	25.68%	10.81%	22.70%	114.81%	26.32%	0.00%	0.00%	26.87%	0.00%	22.50%	21.30%
Return on Invested Capital (ROIC)	8.98%	5.15%	18.78%	-0.78%	5.64%	-12.20%	0.56%	7.93%	7.38%	10.70%	15.46%
ROIC Less NNEP Spread (ROIC-NNEP)	8.61%	5.01%	17.57%	-0.68%	4.33%	-8.90%	-1.73%	6.44%	1.34%	0.18%	13.11%
Return on Net Nonoperating Assets (RNNOA)	1.60%	1.08%	5.03%	-0.22%	1.42%	-2.71%	-0.62%	2.23%	0.47%	0.05%	3.29%
Return on Equity (ROE)	10.58%	6.23%	23.82%	-0.99%	7.05%	-14.91%	-0.06%	10.15%	7.85%	10.74%	18.76%
Cash Return on Invested Capital (CROIC)	10.57%	18.81%	5.64%	11.44%	14.91%	-1.08%	4.17%	3.27%	0.59%	7.18%	-9.78%
Operating Return on Assets (OROA)	8.76%	4.82%	17.16%	3.86%	5.67%	-11.82%	0.89%	8.13%	-1.82%	8.60%	12.53%
Return on Assets (ROA)	5.87%	3.52%	12.31%	-0.48%	2.94%	-6.29%	-1.45%	4.50%	0.51%	1.87%	8.49%
Return on Common Equity (ROCE)	10.58%	6.23%	23.82%	-0.99%	7.05%	-14.91%	-0.06%	10.15%	7.85%	10.74%	18.76%
Return on Equity Simple (ROE_SIMPLE)	9.35%	0.00%	4.04%	-2.38%	0.14%	0.00%	2.87%	7.06%	9.25%	0.00%	12.54%
Net Operating Profit after Tax (NOPAT)	5.65	3.57	13	-0.56	3.61	-7.91	0.35	5.78	4.97	7.75	9.13
NOPAT Margin	5.82%	3.45%	13.53%	-0.56%	4.04%	-8.25%	0.36%	5.23%	4.91%	6.64%	9.11%
Net Nonoperating Expense Percent (NNEP)	0.37%	0.15%	1.22%	-0.09%	1.31%	-3.30%	2.29%	1.48%	6.04%	10.52%	2.35%
Return On Investment Capital (ROIC_SIMPLE)	2.07%	1.35%	-	-	-	-2.78%	-	-	-	2.69%	-
Cost of Revenue to Revenue	77.94%	77.85%	77.46%	77.93%	79.42%	82.59%	85.01%	78.08%	79.17%	81.23%	76.85%
SG&A Expenses to Revenue	12.99%	12.77%	11.47%	11.94%	12.98%	12.62%	11.60%	11.59%	12.34%	9.08%	10.28%
R&D to Revenue	1.13%	1.06%	1.01%	1.10%	1.34%	1.25%	1.23%	0.91%	1.18%	1.20%	1.00%
Operating Expenses to Revenue	14.23%	18.28%	5.03%	18.25%	15.10%	29.20%	14.48%	14.76%	13.82%	10.20%	11.58%
Earnings before Interest and Taxes (EBIT)	8.20	4.80	18	4.00	5.20	-11	0.80	8.50	-1.80	9.20	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	11	11	20	6.50	7.70	-4.60	4.10	12	1.60	17	15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.57	1.55	1.49	1.31	1.05	1.61	1.68	2.01	1.62	1.92
Price to Tangible Book Value (P/TBV)	2.07	2.44	2.43	2.41	2.09	1.68	2.59	2.66	3.18	2.60	3.11
Price to Revenue (P/Rev)	0.76	0.88	0.91	0.80	0.70	0.55	0.78	0.84	1.00	0.79	0.92
Price to Earnings (P/E)	14.40	18.70	38.38	0.00	916.76	0.00	56.02	23.72	21.68	12.47	15.28
Dividend Yield	5.70%	4.05%	4.08%	4.53%	5.08%	6.23%	4.24%	3.88%	3.26%	4.18%	3.74%
Earnings Yield	6.95%	5.35%	2.61%	0.00%	0.11%	0.00%	1.79%	4.22%	4.61%	8.02%	6.55%
Enterprise Value to Invested Capital (EV/IC)	1.34	1.54	1.51	1.44	1.32	1.06	1.47	1.51	1.63	1.49	1.69
Enterprise Value to Revenue (EV/Rev)	0.86	0.98	1.08	0.99	0.88	0.72	0.96	1.04	1.15	0.95	1.11
Enterprise Value to EBITDA (EV/EBITDA)	7.13	8.42	15.52	36.25	21.89	22.57	13.57	10.79	10.79	6.36	7.87
Enterprise Value to EBIT (EV/EBIT)	9.93	12.06	25.89	0.00	96.09	0.00	24.47	16.05	15.37	8.98	10.77
Enterprise Value to NOPAT (EV/NOPAT)	15.05	18.40	33.92	0.00	247.09	99.80	17.13	13.53	13.34	11.54	14.57
Enterprise Value to Operating Cash Flow (EV/OCF)	6.52	7.48	9.96	9.40	7.79	11.16	13.90	20.67	45.68	25.37	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	12.58	7.74	26.53	11.84	8.24	0.00	36.01	48.09	294.31	21.38	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.20	0.21	0.31	0.36	0.37	0.34	0.39	0.43	0.31	0.39	0.44
Long-Term Debt to Equity	0.20	0.19	0.29	0.36	0.37	0.32	0.38	0.43	0.31	0.27	0.32
Financial Leverage	0.19	0.22	0.29	0.32	0.33	0.30	0.36	0.35	0.35	0.26	0.25
Leverage Ratio	1.76	1.75	1.85	1.89	1.90	1.86	1.96	1.93	1.99	1.86	2.00
Compound Leverage Factor	1.59	1.35	1.71	1.27	1.39	2.13	-1.96	1.52	3.42	1.62	1.83
Debt to Total Capital	16.87%	17.04%	23.59%	26.45%	27.16%	25.35%	28.01%	30.04%	23.68%	28.15%	30.77%
Short-Term Debt to Total Capital	0.40%	1.17%	1.26%	0.07%	0.10%	1.62%	0.39%	0.00%	0.00%	8.67%	8.86%
Long-Term Debt to Total Capital	16.47%	15.87%	22.34%	26.38%	27.05%	23.74%	27.62%	30.04%	23.68%	19.48%	21.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	83.13%	82.96%	76.41%	73.55%	72.84%	74.65%	71.99%	69.96%	76.32%	71.85%	69.23%
Debt to EBITDA	0.95	0.99	2.60	7.13	4.96	5.55	2.65	2.24	1.45	1.28	1.52
Net Debt to EBITDA	0.81	0.85	2.43	6.65	4.49	5.32	2.59	2.04	1.40	1.07	1.31
Long-Term Debt to EBITDA	0.93	0.93	2.46	7.12	4.94	5.20	2.62	2.24	1.45	0.89	1.08
Debt to NOPAT	2.01	2.17	5.69	-50.48	56.00	24.56	3.35	2.81	1.80	2.32	2.82
Net Debt to NOPAT	1.72	1.85	5.32	-47.07	50.64	23.54	3.28	2.55	1.73	1.94	2.43
Long-Term Debt to NOPAT	1.96	2.02	5.39	-50.34	55.79	22.99	3.30	2.81	1.80	1.61	2.00
Altman Z-Score	2.94	2.99	2.95	2.80	2.73	2.56	2.88	2.94	3.12	2.80	2.97
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.02	1.88	2.18	2.39	2.56	2.60	2.37	2.65	1.91	1.82	1.79
Quick Ratio	0.67	0.67	0.87	0.87	0.92	0.87	0.89	1.02	0.68	0.73	0.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	10	32	17	33	44	-14	-12	-18	-30	-8.35	-45
Operating Cash Flow to CapEx	450.00%	850.00%	406.25%	329.63%	264.29%	842.11%	442.31%	455.17%	-720.00%	616.13%	156.52%
Free Cash Flow to Firm to Interest Expense	12.69	29.24	12.04	25.18	31.58	-8.63	-7.59	-9.90	-23.33	-6.96	-45.07
Operating Cash Flow to Interest Expense	6.75	23.18	9.29	6.85	2.64	10.00	7.19	7.33	-11.08	15.92	3.60
Operating Cash Flow Less CapEx to Interest Expense	5.25	20.45	7.00	4.77	1.64	8.81	5.56	5.72	-12.62	13.33	1.30
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.04	1.04	0.96	0.96	0.97	1.04	1.08	1.06	1.02	1.09	1.06
Accounts Receivable Turnover	7.00	6.94	5.30	5.75	5.86	6.64	6.26	5.82	5.95	6.74	6.48
Inventory Turnover	3.55	3.41	3.00	2.99	2.92	3.17	3.11	3.02	2.85	3.26	3.21
Fixed Asset Turnover	6.36	6.19	5.48	5.47	5.60	5.72	5.69	5.49	5.33	5.13	4.96
Accounts Payable Turnover	10.31	10.92	9.10	9.80	9.09	10.21	10.24	9.68	8.71	9.45	10.53
Days Sales Outstanding (DSO)	52.12	52.62	68.89	63.43	62.26	54.98	58.29	62.68	61.36	54.14	56.29
Days Inventory Outstanding (DIO)	102.94	106.98	121.69	121.88	124.81	115.04	117.46	120.88	127.88	112.03	113.70
Days Payable Outstanding (DPO)	35.41	33.44	40.10	37.24	40.14	35.73	35.65	37.72	41.90	38.62	34.67
Cash Conversion Cycle (CCC)	119.65	126.17	150.47	148.07	146.93	134.28	140.10	145.83	147.34	127.55	135.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	257	248	275	262	261	277	279	295	302	271	266
Invested Capital Turnover	1.54	1.49	1.39	1.37	1.40	1.48	1.56	1.51	1.50	1.61	1.70
Increase / (Decrease) in Invested Capital	-4.50	-29	-3.40	-33	-41	5.90	13	24	35	16	54
Enterprise Value (EV)	344	382	414	377	346	293	409	444	493	403	449
Market Capitalization	305	344	349	308	275	224	330	361	429	335	374
Book Value per Share	$8.48	$8.19	$8.22	$7.69	$7.84	$7.91	$7.63	$7.99	$7.95	$7.62	$7.12
Tangible Book Value per Share	$5.50	$5.26	$5.25	$4.75	$4.90	$4.95	$4.73	$5.03	$5.02	$4.75	$4.39
Total Capital	273	265	295	281	289	285	285	308	280	289	282
Total Debt	46	45	70	74	78	72	80	92	66	81	87
Total Long-Term Debt	45	42	66	74	78	68	79	92	66	56	62
Net Debt	39	38	65	69	71	69	78	84	64	68	75
Capital Expenditures (CapEx)	1.20	3.00	3.20	2.70	1.40	1.90	2.60	2.90	2.00	3.10	2.30
Debt-free, Cash-free Net Working Capital (DFCFNWC)	84	79	106	99	106	106	110	121	100	103	101
Debt-free Net Working Capital (DFNWC)	90	85	110	104	113	109	111	129	102	116	113
Net Working Capital (NWC)	89	82	106	104	113	104	110	129	102	91	88
Net Nonoperating Expense (NNE)	0.15	0.07	0.75	-0.06	0.91	-2.11	1.65	1.08	4.47	5.75	1.13
Net Nonoperating Obligations (NNO)	30	29	50	55	51	64	73	80	88	64	71
Total Depreciation and Amortization (D&A)	3.20	6.00	2.70	2.50	2.50	6.30	3.30	3.40	3.40	7.70	3.40
Debt-free, Cash-free Net Working Capital to Revenue	20.90%	20.13%	27.50%	25.99%	26.99%	26.17%	25.74%	28.23%	23.29%	24.33%	24.90%
Debt-free Net Working Capital to Revenue	22.48%	21.74%	28.56%	27.20%	28.80%	26.81%	26.09%	30.14%	23.78%	27.37%	27.74%
Net Working Capital to Revenue	22.20%	20.95%	27.60%	27.14%	28.72%	25.68%	25.83%	30.14%	23.78%	21.47%	21.57%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.21	$0.14	$0.47	($0.02)	$0.10	($0.21)	($0.05)	$0.17	$0.02	$0.08	$0.29
Adjusted Weighted Average Basic Shares Outstanding	26.73M	26.74M	26.81M	26.83M	26.82M	26.83M	26.90M	26.92M	26.92M	26.93M	27.30M
Adjusted Diluted Earnings per Share	$0.20	$0.13	$0.47	($0.02)	$0.10	($0.21)	($0.05)	$0.17	$0.02	$0.07	$0.29
Adjusted Weighted Average Diluted Shares Outstanding	27.13M	26.74M	26.93M	26.93M	26.87M	26.83M	27.02M	27.07M	27.07M	26.93M	27.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.77M	26.74M	26.78M	27.39M	26.84M	26.83M	26.87M	26.92M	26.93M	26.93M	27.21M
Normalized Net Operating Profit after Tax (NOPAT)	5.72	5.71	9.12	3.43	4.13	-6.51	1.47	7.61	5.18	7.67	9.37
Normalized NOPAT Margin	5.90%	5.52%	9.18%	3.44%	4.62%	-6.79%	1.51%	6.89%	5.11%	6.57%	9.35%
Pre Tax Income Margin	7.63%	3.58%	16.40%	2.71%	4.25%	-13.03%	-0.82%	6.07%	-3.06%	6.86%	10.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.25	4.36	12.64	3.08	3.71	-6.81	0.50	4.72	-1.38	7.67	11.80
NOPAT to Interest Expense	7.06	3.24	9.61	-0.43	2.58	-4.94	0.22	3.21	3.82	6.46	9.13
EBIT Less CapEx to Interest Expense	8.75	1.64	10.36	1.00	2.71	-8.00	-1.13	3.11	-2.92	5.08	9.50
NOPAT Less CapEx to Interest Expense	5.56	0.52	7.32	-2.51	1.58	-6.13	-1.41	1.60	2.28	3.88	6.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	66.04%	76.09%	153.85%	-285.71%	4,666.67%	-736.84%	238.98%	93.42%	72.22%	52.79%	57.14%
Augmented Payout Ratio	77.36%	88.59%	176.92%	-328.57%	5,433.33%	-878.95%	347.46%	153.29%	125.25%	94.42%	100.41%

Frequently Asked Questions About Luxfer's Financials

When does Luxfer's fiscal year end?

According to the most recent income statement we have on file, Luxfer's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Luxfer's net income changed over the last 2 years?

Luxfer's net income appears to be on a downward trend, with a most recent value of $18.40 million in 2024, falling from $26.90 million in 2022. The previous period was -$1.90 million in 2023.

What is Luxfer's operating income?

Luxfer's total operating income in 2024 was $30.10 million, based on the following breakdown:

Total Gross Profit: $85.70 million
Total Operating Expenses: $55.60 million

How has Luxfer revenue changed over the last 2 years?

Over the last 2 years, Luxfer's total revenue changed from $423.40 million in 2022 to $391.90 million in 2024, a change of -7.4%.

How much debt does Luxfer have?

Luxfer's total liabilities were at $162.90 million at the end of 2024, a 2.1% increase from 2023, and a 18.5% decrease since 2022.

How much cash does Luxfer have?

In the past 2 years, Luxfer's cash and equivalents has ranged from $2.30 million in 2023 to $12.60 million in 2022, and is currently $4.10 million as of their latest financial filing in 2024.

How has Luxfer's book value per share changed over the last 2 years?

Over the last 2 years, Luxfer's book value per share changed from 7.62 in 2022 to 8.19 in 2024, a change of 7.6%.

Related Companies

This page (NYSE:LXFR) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Luxfer (LXFR) Financials

Frequently Asked Questions About Luxfer's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Luxfer (LXFR) Financials

Annual Income Statements for Luxfer

Quarterly Income Statements for Luxfer

Annual Cash Flow Statements for Luxfer

Quarterly Cash Flow Statements for Luxfer

Annual Balance Sheets for Luxfer

Quarterly Balance Sheets for Luxfer

Annual Metrics And Ratios for Luxfer

Quarterly Metrics And Ratios for Luxfer

Frequently Asked Questions About Luxfer's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools